Skip to main content

Postmenopausal hormone therapy: the pros and cons

Buy Article:

$51.00 plus tax (Refund Policy)



The use of postmenopausal hormone therapy (HT) has recently generated much debate following the results of various large randomised controlled trials. This has challenged physicians to reassess the use of HT in each individual woman within the realm of her symptomatology and risk profile for long-term illnesses. There are several areas of definite benefit or risk and many areas of uncertainty. The results of recent randomised controlled trials pertain to the specific HT regimens used and the characteristics of the study groups, such that the conclusions cannot be extrapolated to the use of HT in general. (Intern Med J 2004; 34: 109−114)

Keywords: hormone therapy; menopause; risk versus benefit

Document Type: Research Article


Affiliations: The Jean Hailes Foundation, National Health and Medical Research Council Centre of Clinical Research Excellence, Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria, Australia

Publication date: March 1, 2004

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more